List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 604 studies with search of: Vincristine
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Vincristine, DOXIL® (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Conditions: Myeloma Proteins;   Multiple Myeloma;   Myeloma;   M-Protein
Intervention: Drug: Vincristine, DOXIL (doxorubicin HCl liposomal injection), and Dexamethasone (VDD) vs. Vincristine, Doxorubicin and Dexamethasone (VAD)
2 Recruiting Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Intervention: Drug: Marqibo® (vincristine sulfate liposomes injection)
3 Recruiting Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas
Condition: Hemangioma
Interventions: Drug: Vincristine;   Drug: Prednisone
4 Completed Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: dexamethasone;   Drug: bortezomib;   Drug: doxorubicin;   Drug: vincristine
5 Active, not recruiting Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive
Conditions: Leukemia, Lymphocytic, Acute;   Philadelphia Chromosome;   Blast Crisis;   Leukemia, Myeloid, Chronic
Interventions: Drug: Imatinib mesylate;   Drug: Interferon;   Drug: Vincristine;   Drug: Dexamethasone
6 Active, not recruiting Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients
Condition: Ewing's Sarcoma
Interventions: Drug: Vincristine;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Dexrazoxane;   Biological: ImmTher
7 Recruiting Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage
Condition: Leukemia, Lymphocytic, Acute
Interventions: Drug: Methotrexate;   Drug: Vincristine;   Drug: PEG-l-asparaginase;   Drug: Dexamethasone;   Drug: Rituximab
8 Recruiting A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic Origin
Condition: Refractory Solid Tumors in Children
Intervention: Drug: combination of Irinotecan, vincristine, temozolomide and bevacizumab
9 Active, not recruiting Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies
Conditions: Non-Hodgkins Lymphoma;   Hodgkin's Disease;   Acute Lymphoblastic Leukemia
Interventions: Drug: Dexamethasone;   Drug: Irintotecan;   Drug: Vincristine
10 Not yet recruiting Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma
Condition: Retinoblastoma
Interventions: Drug: Carboplatin Subtenon;   Drug: Topotecan Hydrochloride;   Drug: Vincristine;   Drug: Filgrastim
11 Completed Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
Conditions: Sarcoma, Kaposi;   HIV Infections
Interventions: Drug: Doxorubicin hydrochloride (liposomal);   Drug: Filgrastim;   Drug: Bleomycin sulfate;   Drug: Vincristine sulfate
12 Active, not recruiting Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: doxorubicin hydrochloride;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate
13 Recruiting Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma
Condition: Metastatic Malignant Uveal Melanoma
Intervention: Drug: Marqibo® (vincristine sulfate liposomes injection)
14 Recruiting Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
Conditions: Kidney Cancer;   Leukemia;   Sarcoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Biological: dactinomycin;   Drug: vincristine sulfate;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: liquid chromatography;   Other: mass spectrometry;   Other: pharmacological study
15 Completed Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction
Condition: Malignant Melanoma
Intervention: Drug: Vincristine Sulfate Liposomes Injection
16 Completed Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Vincristine Sulfate Liposomes Injection;   Drug: Dexamethasone
17 Recruiting Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine
Condition: Lymphoma
Interventions: Drug: Methotrexate and temozolomide;   Drug: Methotrexate , procarbazine ,vincristine ,cytarabine
18 Completed A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia
Conditions: Acute Lymphocytic Leukemia;   Leukemia
Intervention: Drug: Vincristine
19 Completed Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma
Conditions: Sarcoma, Kaposi;   HIV Infections
Interventions: Drug: Doxorubicin hydrochloride (liposomal);   Drug: Bleomycin sulfate;   Drug: Vincristine sulfate
20 Active, not recruiting A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma
Conditions: Sarcoma, Kaposi;   HIV Infections
Interventions: Drug: Doxorubicin hydrochloride (liposomal);   Drug: Bleomycin sulfate;   Drug: Vincristine sulfate;   Drug: Doxorubicin hydrochloride

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services